Randomized controlled trial, magnesium bisglycinate, 2025
PMID 40918053 · n=155 · 250 mg/day
Adults taking magnesium bisglycinate for four weeks reported improved insomnia-severity scores versus placebo. The closest published trial to HAVN1's form and dose.



